1[1]CINES DB,POLLAK ES,BUCK CA,et al.Endothelial cells in physiology and in the pathophysiology of vascular disorders[J].Blood,1998,91 (10):3527-3561.
2[2]MENDES RIBEIRO AC,BRUNINI TM,ELLORY JC,et al.Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure[J].Cardiovasc Res,2001,49 (4):697-712.
3[3]PURANIK R,CELERMAJER DS.Smoking and endothelial function[J].Prog Cardiovasc Dis,2003,45 (6):443-584.
4[4]SCHACHINGER V,BRITTEN M,ZEIHER A.Prognostic impact of coronary vasodilator dysfunction on adverse longterm outcome of coronary heart disease[J].Circulation,2000,101(16):1899-1906.
5[5]HALCOX J,SCHENKE W,ZALOS G,et al.Prognostic value of coronary vascular endothelial dysfunction[J].Circulation,2001,104(25):3091-3096.
6[6]SOUMITRO P,KAUSTUBH D,DEBABRATA M.Central role of p53 on regulation of vascular permeability factor vascular/endothelial growth factor expression in mammary carcinoma[J].Cancer Res,2001,61 (18):6952-6957.
9Reddy KG, Nair RN, Sheehan HM, et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis[J]. J Am Coll Cardiol, 1994, 23(4): 833-843.
10Okumura K, Yasue H, Matsuyama K, et al. Effect of acetylcholine on the highly stenotic coronary artery:difference between the constrictor response of the infarct-related coronary artery and that of the noninfarctrelated artery[J]. J Am Coll Cardiol, 1992,
10Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises part Ⅰ : aging arteries: a"set up" for vascular disease[J]. Circulation, 2003, 107(1):139- 146
